Black Forest Medical GmbH appears in FDA device records as the applicant for a single traditional 510(k) in the supplied collection, K262229, decided substantially equivalent on 2026-10-27. The filing describes the DORO® Headrest System for AVA, classified as a neurosurgical head holder or skull clamp in Class II under regulation 882.4460, product code HBL, with neurology as the review panel. The applicant address on the filing is Boetzinger Strasse 86, 79117 Freiburg, Germany, and the listed contact is Gabriel Siedle. [1][6]
The K262229 clearance and its scope
K262229 was received on 2026-06-30 and decided on 2026-10-27 with decision code SESE, meaning substantially equivalent. The clearance type is Traditional, the third-party review flag is N, and the submission includes a summary rather than only a statement. The device is listed as the DORO® Headrest System for AVA, with the classification name Holder, Head, Neurosurgical (Skull Clamp) and device class 2. [1][6]
The regulation cited is 21 CFR 882.4460, product code HBL, with the advisory committee recorded as NE, Neurology. The same record set shows the applicant's city as Freiburg and country code DE, with postal code 79117. These are filing details, not a statement about where the company is headquartered or where devices are manufactured. [1][6]
DORO product families named in company material
Black Forest Medical's own catalogue and site navigation name DORO as a product family, organized by surgical procedure and product category. The categories listed are cranial stabilization and brain retraction, with services split by adult patients, pediatric patients, imaging environment and non-imaging environment. The catalogue frames neurosurgical interventions as time-sensitive and workflow-dependent, and presents the company's stated aim of supporting surgical teams. [3][4][5]
A separate FDA clearance, K203505 from 2021, covers the DORO QR3 Headrest System (Aluminum) under the same regulation, 21 CFR 882.4460, and the same product code HBL. That letter is addressed to pro med instruments GmbH at Bötzinger Straße 38, 79111 Freiburg im Breisgau, with regulatory correspondence routed to a blackforestmedical.com address. The 2021 letter names a different legal applicant than K262229, so the two clearances should not be merged into one applicant record. [7]
Applicant identity and corporate naming
The company's website lists Black Forest Medical GmbH in Freiburg, Germany, alongside a US subsidiary, Black Forest Medical North America, Inc., in Cape Coral, Florida. The catalogue carries the same US entity and address, and its copyright line reads Black Forest Medical GmbH, 01/2026. The catalogue also refers to the Black Forest Medical Group when describing its support for neurosurgical teams. [3][4]
The relationship between Black Forest Medical GmbH and pro med instruments GmbH is not stated in the public documents beyond the shared regulation, product code, DORO naming and Freiburg-area addresses. Any parent, predecessor or brand-ownership link between the two legal entities is unknown from these documents and should not be assumed from the naming overlap. [3][7]
What the filing record does and does not show
The supplied collection contains one linked 510(k) record, K262229, and its decision count is one SESE. That count reflects the supplied filings as of the snapshot date, not total company sales, total portfolio size or safety performance. The record sample is the same single entry, so the sample decision count and the collection decision count are both one and describe the same filing. [1]
The company's site notes that some products are not approved for sale in all countries and directs readers to contact the company for availability in a given country. No source in this set documents commercial availability, certifications, clinical outcomes or independent testing of the DORO systems. The catalogue itself states that errors cannot be excluded and that product changes are reserved. [3][4][5]

